间歇性禁食作为非酒精性脂肪性肝病的一种治疗方法：证据有哪些？
Intermittent Fasting as a Treatment for Nonalcoholic Fatty Liver Disease: What Is the Evidence?
作者信息
Memel Zoe N, Wang Jeffrey, Corey Kathleen E
机构信息
Harvard Medical School Boston MA.
Department of Medicine Massachusetts General Hospital Boston MA.
出版信息
Clin Liver Dis (Hoboken). 2022 Feb 3;19(3):101-105. doi: 10.1002/cld.1172. eCollection 2022 Mar.
Abstract
Content available: Author Interview and Audio Recording.
摘要
可获取的内容
作者访谈及音频记录。
相似文献
1
Intermittent Fasting as a Treatment for Nonalcoholic Fatty Liver Disease: What Is the Evidence?
Clin Liver Dis (Hoboken). 2022 Feb 3;19(3):101-105. doi: 10.1002/cld.1172. eCollection 2022 Mar.
2
The Shift from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease.
Clin Liver Dis (Hoboken). 2022 Nov 25;20(5):157-161. doi: 10.1002/cld.1250. eCollection 2022 Nov.
3
Improvement in nonalcoholic fatty liver disease through bariatric surgery.
Clin Liver Dis (Hoboken). 2022 Jul 22;20(1):13-17. doi: 10.1002/cld.1229. eCollection 2022 Jul.
4
Duodenal mucosal resurfacing for nonalcoholic fatty liver disease.
Clin Liver Dis (Hoboken). 2022 Nov 25;20(5):166-169. doi: 10.1002/cld.1255. eCollection 2022 Nov.
5
The diagnosis and management of nonalcoholic fatty liver disease: A patient-friendly summary of the 2018 AASLD guidelines.
Clin Liver Dis (Hoboken). 2022 Jul 1;19(6):222-226. doi: 10.1002/cld.1216. eCollection 2022 Jun.
6
Nonalcoholic Fatty Liver Disease: The Role of Visceral Adipose Tissue.
Clin Liver Dis (Hoboken). 2022 Jan 28;19(3):106-110. doi: 10.1002/cld.1183. eCollection 2022 Mar.
7
Hyperinsulinemia and the development of nonalcoholic Fatty liver disease in nondiabetic adults.
Am J Med. 2011 Jan;124(1):69-76. doi: 10.1016/j.amjmed.2010.08.012.
8
CON: Should patients with nonalcoholic steatohepatitis fibrosis undergo bariatric surgery as a primary treatment?
Clin Liver Dis (Hoboken). 2022 Jul 22;20(1):9-12. doi: 10.1002/cld.1226. eCollection 2022 Jul.
9
Using Telehealth for Diagnosis and Management of Non-Alcoholic Fatty Liver Disease.
Clin Liver Dis (Hoboken). 2022 Apr 29;19(4):171-175. doi: 10.1002/cld.1191. eCollection 2022 Apr.
10
The Impact of Nonalcoholic Fatty Liver Disease on the Outcomes of Coronavirus Disease 2019 Infection.
Clin Liver Dis (Hoboken). 2022 Jan 24;19(1):29-31. doi: 10.1002/cld.1169. eCollection 2022 Jan.
引用本文的文献
1
The effects of meal patterns on liver steatosis, fibrosis, and biochemical factors in patients with nonalcoholic fatty liver disease: a randomized controlled clinical trial.
J Diabetes Metab Disord. 2024 Jan 5;23(1):987-997. doi: 10.1007/s40200-023-01375-2. eCollection 2024 Jun.
2
Time-Restricted Feeding Attenuates Metabolic Dysfunction-Associated Steatohepatitis and Hepatocellular Carcinoma in Obese Male Mice.
Cancers (Basel). 2024 Apr 16;16(8):1513. doi: 10.3390/cancers16081513.
3
Time-Restricted Eating and Its Metabolic Benefits.
J Clin Med. 2023 Nov 9;12(22):7007. doi: 10.3390/jcm12227007.
4
The Impact of Intermittent Fasting on Non-Alcoholic Fatty Liver Disease in Older Adults: A Review of Clinicaltrials.gov Registry.
Diabetes Metab Syndr Obes. 2023 Oct 6;16:3115-3121. doi: 10.2147/DMSO.S430740. eCollection 2023.
5
Dietary strategies in non-alcoholic fatty liver disease patients: From evidence to daily clinical practice, a systematic review.
United European Gastroenterol J. 2023 Sep;11(7):663-689. doi: 10.1002/ueg2.12443. Epub 2023 Jul 25.
6
A Scoping Review of the Relationship between Intermittent Fasting and the Human Gut Microbiota: Current Knowledge and Future Directions.
Nutrients. 2023 Apr 26;15(9):2095. doi: 10.3390/nu15092095.
7
Implications of Ramadan Fasting in the Setting of Gastrointestinal Disorders.
Cureus. 2023 Mar 31;15(3):e36972. doi: 10.7759/cureus.36972. eCollection 2023 Mar.
8
Small Intestinal Bacterial Overgrowth and Non-Alcoholic Fatty Liver Disease: What Do We Know in 2023?
Nutrients. 2023 Mar 8;15(6):1323. doi: 10.3390/nu15061323.
9
Indian National Association for Study of the Liver (INASL) Guidance Paper on Nomenclature, Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease (NAFLD).
J Clin Exp Hepatol. 2023 Mar-Apr;13(2):273-302. doi: 10.1016/j.jceh.2022.11.014. Epub 2022 Dec 7.
10
Obesity, cancer risk, and time-restricted eating.
Cancer Metastasis Rev. 2022 Sep;41(3):697-717. doi: 10.1007/s10555-022-10061-3. Epub 2022 Aug 19.
本文引用的文献
1
The Impact of Ramadan Fasting on Fatty Liver Disease Severity: A Retrospective Case Control Study from Israel.
Isr Med Assoc J. 2021 Feb;23(2):94-98.
2
Effects of Intermittent Fasting on Health, Aging, and Disease.
N Engl J Med. 2019 Dec 26;381(26):2541-2551. doi: 10.1056/NEJMra1905136.
3
Effects of alternate-day fasting on body weight and dyslipidaemia in patients with non-alcoholic fatty liver disease: a randomised controlled trial.
BMC Gastroenterol. 2019 Dec 18;19(1):219. doi: 10.1186/s12876-019-1132-8.
4
Effects of Periodic Fasting on Fatty Liver Index-A Prospective Observational Study.
Nutrients. 2019 Oct 30;11(11):2601. doi: 10.3390/nu11112601.
5
A Randomised Controlled Trial on the Effectiveness and Adherence of Modified Alternate-day Calorie Restriction in Improving Activity of Non-Alcoholic Fatty Liver Disease.
Sci Rep. 2019 Aug 2;9(1):11232. doi: 10.1038/s41598-019-47763-8.
6
Ramadan fasting improves liver function and total cholesterol in patients with nonalcoholic fatty liver disease.
Int J Vitam Nutr Res. 2020 Jan;90(1-2):95-102. doi: 10.1024/0300-9831/a000442. Epub 2019 Apr 1.
7
Intermittent Fasting Promotes White Adipose Browning and Decreases Obesity by Shaping the Gut Microbiota.
Cell Metab. 2017 Nov 7;26(5):801. doi: 10.1016/j.cmet.2017.10.007.
8
The Effects of Ramadan Fasting on Body Composition, Blood Pressure, Glucose Metabolism, and Markers of Inflammation in NAFLD Patients: An Observational Trial.
J Am Coll Nutr. 2017 Nov-Dec;36(8):640-645. doi: 10.1080/07315724.2017.1339644. Epub 2017 Sep 18.
9
Time-restricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet.
Cell Metab. 2012 Jun 6;15(6):848-60. doi: 10.1016/j.cmet.2012.04.019. Epub 2012 May 17.
Zotero 插件